Search

Haleon PLC

Suletud

Sektor Tervishoid

388.7 0.28

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

387.8

Max

389.7

Põhinäitajad

By Trading Economics

Sissetulek

58M

423M

Müük

-144M

2.8B

P/E

Sektori keskmine

29.48

103.001

Aktsiakasum

0.033

Dividenditootlus

1.275

Kasumimarginaal

14.491

EBITDA

-2M

687M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-3.4 downside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.27%

7.76%

Järgmine dividendimakse kuupäev

19. sept 2024

Turustatistika

By TradingEconomics

Turukapital

59M

35B

Eelmine avamishind

388.42

Eelmine sulgemishind

388.7

Uudiste sentiment

By Acuity

50%

50%

42 / 365 Pingereas Healthcare

Haleon PLC Graafik

Seotud uudised

1. aug 2024, 06:54 UTC

Tulu

Haleon Lifts Profit Guidance on Profit Rise

26. juuni 2024, 13:33 UTC

Omandamised, ülevõtmised, äriostud

Haleon to Sell Nicotine-Quitting Aid Business for $634 Million -- Update

26. juuni 2024, 12:32 UTC

Omandamised, ülevõtmised, äriostud

Haleon to Sell Nicotine-Quitting Aid Business for $634 Million

17. mai 2024, 06:24 UTC

Omandamised, ülevõtmised, äriostud

GSK Sells Last Haleon Shares for $1.58 Billion

16. mai 2024, 16:46 UTC

Omandamised, ülevõtmised, äriostud

GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update

16. mai 2024, 16:28 UTC

Omandamised, ülevõtmised, äriostud

GSK to Sell Stake in Haleon Valued at About $1.61 Billion

1. aug 2024, 13:08 UTC

Market Talk
Tulu

Haleon 1H Results Are Positive -- Market Talk

1. aug 2024, 07:08 UTC

Market Talk
Tulu

Haleon's 1H Results Don't Surprise -- Market Talk

1. aug 2024, 06:09 UTC

Tulu

Haleon Launches BuyBack Program Up to GBP185M

1. aug 2024, 06:05 UTC

Tulu

Haleon Now Expects 2024 Operating Profit Growth to Grow High-Single Digit

1. aug 2024, 06:04 UTC

Tulu

Haleon Had Seen Organic Revenue Growth of 4% to 6%

1. aug 2024, 06:04 UTC

Tulu

Haleon Backs 2024 Organic Revenue Growth View

1. aug 2024, 06:03 UTC

Tulu

Haleon Declares Interim Dividend of 2.0p per share

1. aug 2024, 06:02 UTC

Tulu

Haleon 1H Adj EBIT Consensus GBP1.275B

1. aug 2024, 06:02 UTC

Tulu

Haleon 1H Adj Oper Pft GBP1.29B

1. aug 2024, 06:01 UTC

Tulu

Haleon 1H Organic Rev Growth Consensus 3.5%

1. aug 2024, 06:01 UTC

Tulu

Haleon 1H Organic Rev Growth 3.5%

1. aug 2024, 06:01 UTC

Tulu

Haleon 1H Revenue Consensus GBP5.69B

1. aug 2024, 06:01 UTC

Tulu

Haleon 1H Rev GBP5.69B

26. juuni 2024, 11:54 UTC

Omandamised, ülevõtmised, äriostud

Haleon: All Other 2024 Guidance Unchanged

26. juuni 2024, 11:54 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Sale Will Dilute 2024 Rev by 0.5%, Adj Oper Pft by 1%

26. juuni 2024, 11:52 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Sale Allow For NRT Exit Outside US, Trims Business Complexity

26. juuni 2024, 11:51 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Deal Expected to Complete Early 4Q

26. juuni 2024, 11:50 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Use of Proceeds Will Be in Line With Capital Allocation Priorities

26. juuni 2024, 11:49 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Deal Structure Upfront Cash GBP458M, GBP42M Performance-Based Payable

26. juuni 2024, 11:48 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Portfolio Includes Nicotinell, Nicabate, Habitrol and Thrive Available in Gum, Lozenge

26. juuni 2024, 11:47 UTC

Omandamised, ülevõtmised, äriostud

Haleon: Deal Worth GBP500M With Additional Proceeds From Inventory Transfer

26. juuni 2024, 11:46 UTC

Omandamised, ülevõtmised, äriostud

Haleon to Sell Non-US Nicotine Replacement Therapy Business to Dr. Reddy's Laboratories

17. mai 2024, 06:09 UTC

Omandamised, ülevõtmised, äriostud

GSK Sells Last Haleon Shares for $1.58 Bln

16. mai 2024, 15:46 UTC

Omandamised, ülevõtmised, äriostud

GSK PLC: Shares Are Equivalent to Around 4.2% of Haleon's Share Capital

Haleon PLC Prognoos

Hinnasiht

By TipRanks

-3.4% langus

12 kuu keskmine prognoos

Keskmine 374.9 GBX  -3.4%

Kõrge 447 GBX

Madal 300 GBX

Põhineb 10 Wall Streeti analüütiku instrumendi Haleon PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

5

Osta

4

Hoia

1

Müü

Sentiment

By Acuity

42 / 365 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

$

Ettevõttest Haleon PLC

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.